« Nano-arthroscope Allows Researchers To Diagnose Osteoarthritis In Earliest Stages | Main | Medihoney™ Now Available For Ordering »

FDA Approves Silver-Coated Agento™ Breathing Tube For Marketing

By admin | November 21, 2007

The U.S. Food and Drug Administration announced recently that it has cleared for marketing the Agento endotrachael tube (breathing tube) manufactured by CR Bard in Murray Hill, New Jersey.

The Agento tube is coated with a thin layer of silver, which acts to retard the growth of bacteria that can lead to the development of ventilator-associated pneumonia (VAP). It is estimated that up to 15% of patients on a ventilator with an endotracheal tube will develop VAP.

There are an estimated 26,000 deaths a year in the United States due to ventilator-associated pneumonia, according to the Centers for Disease Control. In a recent study, the use of the silver-coated Agento endotracheal tube reduced the incidence of VAP from 7.8% to 4.5%.

Although other medical devices have used the silver coating to reduce microbial infections on their surfaces, the Agento product is the first endotracheal tube to use the technology.

 Copyright 2007 Medgizmo.com

Topics: Critical Care, Infectious Diseases, Pulmonary |

One Response to “FDA Approves Silver-Coated Agento™ Breathing Tube For Marketing”

  1. Webmaster Says:
    June 10th, 2010 at 10:53 am

    Please e-mail me your contacts. I have a question < a href=”http://spottovo.ru/ webmaster@spottovo.ru” >…< /a >…

    Thank you!!!…

Comments